| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fulgent Genetics, Inc. | Director | Common Stock | 8K | $214K | $26.69 | Aug 1, 2022 | Direct |
| uniQure N.V. | Director | Ordinary Shares | 24.1K | $116K | $4.81 | Jun 19, 2024 | Direct |
| uniQure N.V. | Director | Stock Option (Right to Buy) | 15.8K | Jun 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| QURE | uniQure N.V. | Jun 19, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
| QURE | uniQure N.V. | Jun 13, 2024 | 1 | -$11.4K | 4 | Jun 18, 2024 | Director |
| CGON | CG Oncology, Inc. | Jan 24, 2024 | 0 | $0 | 3 | Jan 24, 2024 | Director |
| QURE | uniQure N.V. | Jun 13, 2023 | 3 | -$43.1K | 4 | Jun 20, 2023 | Director |
| QURE | uniQure N.V. | Feb 27, 2023 | 1 | -$7.67K | 4 | Mar 1, 2023 | Director |
| FLGT | Fulgent Genetics, Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Director |
| FLGT | Fulgent Genetics, Inc. | Aug 1, 2022 | 0 | $0 | 3 | Aug 3, 2022 | Director |
| QURE | uniQure N.V. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
| QURE | uniQure N.V. | Feb 28, 2022 | 1 | -$13.2K | 4 | Mar 2, 2022 | Director |
| QURE | uniQure N.V. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | Director |